Back to RU Rubric Capital Management LP

TEVATEVA

Showing 8 of 15 quarters

Position history for RURubric Capital Management LP's holdings in Teva Pharmaceutical Industries Limited

As of its Q2 2026 13F, Rubric Capital Management held 15,575,000 shares of TEVA (Teva Pharmaceutical Industries), worth $527.7M. Rubric Capital Management's 13F filings listed TEVA from Q1 2023 to Q2 2026, 14 quarterly filings. TEVA was 4.8% of Rubric Capital Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$374.7M

Total Shares Change

-17M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$39.60
0
2026-Q2
Increased
15.6M
+2.1%
$527.7M4.8%$33.88
59
2026-Q1
Decreased
15.3M
-28.6%
$459.3M4.9%$30.12
0
2025-Q4
Decreased
21.4M
-13.4%
$666.5M8.0%$31.21
0
2025-Q3
Decreased
24.7M
-5.2%
$497.9M5.6%$20.20
0
2025-Q2
Increased
26M
+1.8%
$435.8M6.6%$16.76
62
2025-Q1
Increased
25.6M
+50.3%
$392.7M7.0%$15.37
84
2024-Q4
Increased
17M
+6.2%
$374.7M4.8%$22.04
61

Optional analytics helps us improve. How it’s used